These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20631015)

  • 81. Association between peroxisome proliferator-activated receptor γ gene polymorphism and susceptibility to northwest dryness syndrome.
    Wang Y; Wang X; Zeng B; Guo F; He Y; He J; Liu B
    J Tradit Chin Med; 2017 Apr; 37(2):201-6. PubMed ID: 29960292
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H; Palmgren E; Widgren B; Aurell M
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association of PPAR-γ2 and β3-AR Polymorphisms With Postmenopausal Hypertension.
    Grygiel-Górniak B; Kaczmarek E; Mosor M; Przysławski J; Nowak J
    J Clin Hypertens (Greenwich); 2015 Jul; 17(7):549-56. PubMed ID: 25827163
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ.
    Božina T; Sertić J; Lovrić J; Jelaković B; Šimić I; Reiner Ž
    Genet Test Mol Biomarkers; 2014 Jan; 18(1):32-40. PubMed ID: 24200052
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Association of combined genetic variations in PPARγ, PGC-1α, and LXRα with coronary artery disease and severity in Thai population.
    Yongsakulchai P; Settasatian C; Settasatian N; Komanasin N; Kukongwiriyapan U; Cote ML; Intharapetch P; Senthong V
    Atherosclerosis; 2016 May; 248():140-8. PubMed ID: 27016616
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Are plasma renin activity and aldosterone levels useful as a screening test to differentiate between unilateral and bilateral renal artery stenosis in hypertensive patients?
    Kotliar C; Inserra F; Forcada P; Cavanagh E; Obregon S; Navari C; Castellaro C; Sánchez R
    J Hypertens; 2010 Mar; 28(3):594-601. PubMed ID: 20104188
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Correlations of MMP-9 and PPARγ gene polymorphisms with occurrence of preeclampsia.
    Jia JP; Wu JH; Hu JR
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):771-778. PubMed ID: 35179743
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Association of SNPs in the PPARγ gene and hypertension in a Mongolian population.
    Yang L; Tian RG; Chang PY; Yan MR; Su XL
    Genet Mol Res; 2015 Dec; 14(4):19295-308. PubMed ID: 26782582
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension.
    Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Gupta M; Tyagi S; Jain SK; Pasha MA
    Clin Biochem; 2010 Jan; 43(1-2):136-41. PubMed ID: 19786005
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels.
    van Leeuwen N; Caprio M; Blaya C; Fumeron F; Sartorato P; Ronconi V; Giacchetti G; Mantero F; Fernandes-Rosa FL; Simian C; Peyrard S; Zitman FG; Penninx BW; de Kloet ER; Azizi M; Jeunemaitre X; Derijk RH; Zennaro MC
    Hypertension; 2010 Nov; 56(5):995-1002. PubMed ID: 20855654
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes.
    Stage TB; Christensen MM; Feddersen S; Beck-Nielsen H; Brøsen K
    Pharmacogenet Genomics; 2013 Apr; 23(4):219-27. PubMed ID: 23426382
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African Americans.
    Joseph JJ; Zhou X; Zilbermint M; Stratakis CA; Faucz FR; Lodish MB; Berthon A; Wilson JG; Hsueh WA; Golden SH; Lin S
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2625-33. PubMed ID: 32436940
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients.
    Cho JS; Ihm SH; Jang SW; Chung WB; Choi YS; Shin DI; Seo SM; Park MW; Kim GH; Her SH; Kim CJ; Kim TH; Kang MK; Chang K; Park CS
    Clin Exp Hypertens; 2014; 36(4):195-9. PubMed ID: 24678899
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of angiotensin-converting enzyme genotype on renin-angiotensin components in hypertensives.
    Zee RY; Schrader AP; Morris BJ
    Clin Chim Acta; 1996 Aug; 252(1):33-9. PubMed ID: 8814359
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tagging SNPs in REN, AGTR1 and AGTR2 genes and response of renin activity, angiotensin II and aldosterone concentrations to antihypertensive treatment in Kazakans.
    Yan W; Zhang Y; Shan Z; Wang Q; Huang Y; Wang C; Yan K
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):581-7. PubMed ID: 21810897
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals.
    Le MT; Lobmeyer MT; Campbell M; Cheng J; Wang Z; Turner ST; Chapman AB; Boerwinkle E; Gums JG; Gong Y; Johnson RJ; Johnson JA
    PLoS One; 2013; 8(1):e52062. PubMed ID: 23341889
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients.
    Alderman MH; Ooi WL; Cohen H; Madhavan S; Sealey JE; Laragh JH
    Am J Hypertens; 1997 Jan; 10(1):1-8. PubMed ID: 9008242
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension.
    Zhu H; Sagnella GA; Dong Y; Miller MA; Onipinla A; Markandu ND; MacGregor GA
    J Hypertens; 2004 Jul; 22(7):1269-75. PubMed ID: 15201541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.